|
Volumn 314, Issue 14, 2015, Pages 1447-1448
|
Obstacles to developing cost-lowering health technology the inventor's dilemma
|
Author keywords
[No Author keywords available]
|
Indexed keywords
ACETYLSALICYLIC ACID;
ANTIHYPERTENSIVE AGENT;
FOLIC ACID;
HAEMOPHILUS INFLUENZAE TYPE B VACCINE;
HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR;
LOW DENSITY LIPOPROTEIN CHOLESTEROL;
PROSTATE SPECIFIC ANTIGEN;
DRUG COMBINATION;
BLOOD PRESSURE;
CARDIOVASCULAR DISEASE;
CAUSE OF DEATH;
CEREBROVASCULAR ACCIDENT;
DRUG COST;
DRUG EFFICACY;
DRUG RESEARCH;
DRUG SAFETY;
DRUG TOLERABILITY;
FOOD AND DRUG ADMINISTRATION;
HEALTH CARE ACCESS;
HEALTH CARE COST;
HEALTH CARE PLANNING;
HEALTH CARE POLICY;
HEALTH CARE QUALITY;
HEALTH SERVICE;
HEART INFARCTION;
HUMAN;
HYPERTENSION;
INCIDENCE;
LOW DRUG DOSE;
MEDICAID;
MEDICAL RESEARCH;
MEDICARE;
NOTE;
ORAL REHYDRATION THERAPY;
PATENT;
PHASE 2 CLINICAL TRIAL (TOPIC);
PHASE 3 CLINICAL TRIAL (TOPIC);
PILL;
POLYPILL;
PRIORITY JOURNAL;
ROBOTICS;
SECONDARY PREVENTION;
UNITED STATES;
COST CONTROL;
DEVICE APPROVAL;
DRUG COMBINATION;
ECONOMICS;
FINANCIAL MANAGEMENT;
INVENTOR;
INVESTMENT;
MEDICAL TECHNOLOGY;
ORGANIZATION AND MANAGEMENT;
PATIENT PARTICIPATION;
PHYSICIAN ATTITUDE;
BIOMEDICAL TECHNOLOGY;
COST SAVINGS;
DEVICE APPROVAL;
DRUG COMBINATIONS;
HUMANS;
INVENTORS;
INVESTMENTS;
PATIENT PARTICIPATION;
PHYSICIAN'S ROLE;
RESEARCH SUPPORT AS TOPIC;
UNITED STATES;
UNITED STATES FOOD AND DRUG ADMINISTRATION;
|
EID: 84944037667
PISSN: 00987484
EISSN: 15383598
Source Type: Journal
DOI: 10.1001/jama.2015.10114 Document Type: Note |
Times cited : (4)
|
References (9)
|